Summary: An improved method for the simultaneous gas-chromatographic determination of individual 17-oxosteroids and of pregnanediol in the same sample of urine is described. The method involves the following steps. The urinary sample is chromatographed on Amberlite XAD-2. The fraction containing the steroid conjugates is evaporated; the residue is dissolved in -heptane and the organic phase extracted with water. The steroid glucuronides are hydrolysed by a bacterial ß-glucuronidase; subsequently, the steroid sulphates are solvolysed in ethyl acetate. Free 17-oxosteroids and pregnanediol are separated by two-dimensional thin-layer chromatography. The zone containing the steroids to be investigated is eluted; after evaporation, the residue is treated with N-methyl N-trimethyl silyl trifluoroacetamide. The reaction mixture is injected into a gas Chromatograph; the trimethyl silyl ethers of the individual 17-oxosteroids and of pregnanediol are quantitated by measuring the peak heights.
Introduction the procedure as modified by Norymberski et al. (1) in 1953 has been the most popular one. However, in certain The determination of 17-oxosteroids in urine has been clinical conditions, such as adreno-genital syndrome, in widespread use for more than three decades. Of the carcinoma of the adrenal cortex and gonadal disorders, numerous methods which have been recommended for it is desirable to obtain information about the urinary the measurement of the so-called total 17-oxosteroids, excretion of individual 17-oxosteroids. Moreover, it seems not unreasonable to assume that, in a number of endocrinological disorders, the determination of individual 17-oxosteroids may contribute to a better understanding of the underlying pathobiochemical processes. The first method for the fractionation of 17-oxosteroids was published by Dingemanse and her colleagues (2, 3) and later improved by Kellie & Wade (4) ; the indiviual 17-oxosteroids were separated from each other by chromatography on alumina. These time-consuming methods were succeeded by procedures involving gas chromatography (5, 6, 7) . A critical evaluation of the column chromatography procedures and also of the gas Chromatographie methods makes it likely that, in many instances, results obtained do not reflect the correct values for the individual 17-oxosteroids. This is due mainly to two reasons: (1) Hydrolysis of steroid conjugates whether by hot mineral acids or by enzymes, in a native urine sample without prepurification, leads to artifacts or/and incomplete cleavage £8-11). (2) Insufficient purification of the sample prior to gas chromatography may give rise to false results.
The present method has been developed with the aim of avoiding the formation of artifacts by carrying out hydrolysis of the steroid conjugates in prepurified urine. Moreover, a special thin-layer Chromatographie technique was devised which yields highly purified samples suitable for the quantitative and specific determination by gas chromatography. The high accuracy of the method is ascertained by using radioactive steroid conjugates as internal standards. 
Materials and Equipment
Steroids Pregnanediol (50-pregnane-3a, 20a-diol), aldosterone (18,11-hemiacetal of 110, 21-dihydroxy-3, 20-dioxo-4-pregnen-18-ai), androsterone (3a-hydroxy-5/3-androstan-l 7-one), etiocholanolone (3a-hydroxy-5a-androstan-l 7-one), dehydroepiandrosterone (30-hydroxy-5-androsten-17-one), 11-oxoandrosterone (3α-hydroxy-5a-androstane-ll, 17-dione),. 11-oxoetiocholanolone (3a-hydroxy-50-androstane-ll, 17-dione), 110-hydroxyandrosterone (3α, 110-dihydroxy-5a-androstan-l7-one) and 110-hydroxy-etiocholanolone (3α, ll/3-dihydroxy-50-androstan-17-one) were obtained from Ikapharm, Ramat-Gan, Israel. The purity of steroids was checked by thin-layer and gas liquid chromatography. Stock solutions (final concentration lg/1) were prepared by dissolving steroids in benzene/ethanol (volumes, 90 ml + 10 ml). The solutions are stable for 6 months when kept at + 4 °C. 
Accessories
Water bath, centrifuge, shaker, rotavapor, tanks for thin-layer chromatography, UV-lamp.
Column chromatography
Amberlite XAD-2, coarse, 0.5-1.00 mm diameter (Serva* Entwicklungslabor, Heidelberg, F. R. G.) was first washed with water (five times with the threefold volume of the resin) to remove the fines and then washed with methanol (twice with the twofold volume of the resin) to remove impurities. The purified resin was kept under water at room temperature before use. The columns (20 X 1.0 cm internal diameter) were fitted at the bottom with a G-l sintered glass filter and a capillary outlet. At filling time, the capillary exit was closed by means of a PTFA stop cock and the aqueous suspension of Amberlite (5 g) poured slowly into the column. The resin was allowed to settle under gravity. The upper end of the filled column was covered with glass wool and glass beads (3 mm diameter). After use, the resin was discarded.
Thin-layer chromatography
Aluminium sheets (sizes 20 X 20 cm), coated with silica gel F2S4 (thickness of the layer 0.25 mm) (Merck, Darmstadt, F. R. G.) were prewashed for 24 h with chloroform/methanol volumes, 93 ml + 7 ml), using the technique described by fritter (12) .
(fas liquid chromatography Any gas Chromatograph with a flame ionisation detector may be used (e. g. Philips-Pye, Philips Elektronik Industrie GmbH, Ham-burg, F. R. G.). It contains a siliconised glass column (2.7 m X 2.4 mm internal diameter), packed with a mixture of 1 part 3%OV-210 and 1.8 part 3% OV-225 on Chromosorb WHP 100 -120 mesh (Supelco, Bellefonte, Pa., U.S.A., c/o Packard Instruments, Frankfurt/Main, F. R. G.)· Column temperature: 235 °C. Inlet temperature: 250 °C. Detector temperature: 275 °C. Purged nitrogen was used as carrier gas at a flow rate of 35 ml/min; the flow of hydrogen (50 ml/min) and air (250 ml/min) were adjusted for maximal sensitivity. N-methyl N-trimethyl silyl trifluoracetamide (MSTFA) (Macherey and Nagel, D ren, F. R. G.) was used as silylating agent.
Liquid scintillation counting
Any liquid scintillation spectrometer (e. g. Packard) may be used. The scintillation fluid contained 4 g of 2,5-diphenyl-oxazol (PPO) in 1 1 of dry sulphur-free toluene (Packard Instruments, Frankfurt/ Main, F. R. G.).
Procedure
Collection and storage of urine samples After urine has been collected over a period of 24 h, its volume is measured and then made up with water to 1200 ml or, if more has been excreted, to a larger multiple of 100 ml. The diluted urine can be kept indefinitely at -10 °C without any detectable change in its concentrations of 17-oxosteroids and pregnanediol.
Chromatography on XAD-2 10 ml of urine is used for analysis. The pH is adjusted to 7.0 with 2 mol/1 sodium hydroxide and 0.45 mol/1 phosphate buffer; to each sample, 3,7 kBq (100 nCi) [7o- Extraction of steroid conjugates S ml w-heptane is added to the propanediol solution; the steroid conjugates are then extracted with water (1X3 ml, 2X1 ml).
Enzymatic hydrolysis
To the combined aqueous extracts, the followiiig additions are made: 1 ml of 0.45 mol/1 phosphate buffer, 2500 U 0-glucuronidase, dissolved in 1 ml of 0.075 mol/1 phosphate buffer, 2.5 μ\ of the penicillin G solution, 10 μΐ of the Nebacetin solution, 7 μΐ of the streptomycin solution and 2 dfpps of chloroform. The mixture is incubated for 24 h at 37 °C in a water bath. The free steroids are extracted with ethyl acetate (1 X 10 ml). The extract is transferred to a Kober test tube and the organic phase evaporated under vacuum (Fraction Ej).
Solvolysis
Solvolysis is carried out according to Burstein & Liebermann (14) . The remaining aqueous phase is adjusted to pH l by the addition of 1 mol/1 sulphuric acid; 1.4 g sodium chloride is added arid dissolved by shaking. The mixture is then extracted with ethyl acetate (3 X 5 ml). The extracts are combined by transferring then! separately to the Kober test tube containing fraction EI . This solution is incubated for 24 h at 37 °C in a water bath. At the end of the solvolysis, the ethyl acetate phase is washed with sodium hydrogen carbonate solution (1x1 ml). The aqueous solutions are discarded, and the organic phase is evaporated under vacuum.
Thin-layer chromatography
The residue, containing the liberated steroids from the glucuronide and sulphate fractions, is dissolved in a small volume of chloroform/ methanol (volumes, 90 ml + 10 ml); the solution is applied to the plate as a 2 cm-line. For the localization of the 17-oxosteroids and pregnanediol, reference steroids with a low Rp-value (11-oxoetiocholanolone) and with a high Rp-value (androsterone) are also applied. The chromatogram is developed with cyclohexane/ ethyl acetate/methanol (volumes, 10 ml + 90 ml + 5 ml). The lane with the reference steroids is cut off and sprayed with sulphuric acid; the steroids are made visible by heating the strips at 120 °C for 5 min. After localization of the steroid-containing zone, the thin-layer plate is turned around 90°; since aldosterone has a low Rp-value, as compared with the 17-oxosteroids, and is easily visible under the UV-lamp, it is used as reference steroid for the following thin-layer chromatography steps and applied as a vertical 2 cm-line at a distance of 2 cm. The thin-layer chromatogram (aluminium sheet) is put between two glass plates which are in a horizontal position and cover a glass jar, containing chloroform/methanol (volumes, 93 ml + 7 ml) (15) . About 4/5th of the thin-layer sheet are above the two glass plates and exposed to air. The solvent mixture evaporates as soon as it passes the glass plates. By using this technique, the 17-oxosteroids and pregnanediol fraction as well as aldosterone are concentrated and yield distinct small spots with a diameter less than 1 mm within 15 min of development. The position of aldosterone is checked under UV light. Following this step, the thin-layer chromatogram is developed with chloroform/methanol (volumes, 93 ml + 7 ml) on the usual way. After the solvent has reached a distance of 8 cm from the starting line, the zone containing the 17-oxosteroids and pregnanediol is localised by comparison with authentic androsterone and pregnanediol, using sulphuric acid for visulization. The thin-layer plate is again turned around 90° and the steroid-containing zone concentrated by developing the chromatogram with chloroform/ methanol (volumes, 93 ml + 7 ml) in the same way as described above. The small area containing the 17-oxosteroids and pregnanediol is cut off and put into a glass tube with a sealed-in sintered glass support (G-4) at the bottom. Elution is carried out with 3 ml of chloroform/methanol (volumes, 93 ml + 7 ml); the eluate is collected into a conical glass tube and evaporated under vacuum.
Measurement of radioactivity
The residue is taken up in 100 μΐ benzene/ethanol (volumes, 90 ml + 10 ml). For the determination of recovery, 10 μΐ of the solution is pipetted with a "mikrocap" into a counting vial, containing 10 ml of scintillation fluid.
Gas liquid chromatography
The remaining solution (90 μΐ) is evaporated under vacuum. The residue is treated with 90 μΐ MSTFA for 60 min at 60 °C in the conical glass tube which is stoppered. For the gas Chromatographie determination, 2 μΐ of the MSTFA solution is injected into the column.
Calculation of the results
The amounts of 17-oxosteroids and pregnanediol are calculated from the gas Chromatographie tracings by measuring the peak heights. The excretion of the individual 17-oxosteroids and pregnanediol is calculated according to the following formula Steroid (μηιοΙ/24 h) = mX VX f where: m = amount of steroid in pmol as determined by gas liquid chromatography V = volume of the 24 h-urine in ml K lpmann and Breuer: Simultaneous determination of individuall 7-oxosteroids and of pregnanediol f = conversion factor; 5 Χ 10" 4 , if the volume of the urinary sample is 10 ml and that of the sample injected into the gas Chromatographie column is 2 μΐ R = % recovery as determined from measurement of radioactivity of the internal standard.
Calibration
Reference steroids are treated in the same way as the sample to be investigated. Regression lines are calculated on the basis of measurements of three different amounts of each individual steroid. The amounts of steroids, present in the sample qu ntitated by gas liquid chromatography (m), are calculated by means of the regression lines. 
Tab. 2. Precision of the method calculated from 7 determinations in 4 days (4 series

Results
Criteria of reliability
Precision
The precision of the method within the series was determined for each steroid at various concentrations in threefold to sixfold estimations. The standard deviations (S. D.) and coefficient of variation (CV) at the different concentration levels are given in table 1. The precision from day to day (tab. 2) was calculated from seven determinations of the same urinary sample in four days (4 series).
Accuracy
Using radioactive dehydroepiandrosterone glucuronide and dehydroepiandrosterone sulphate as internal standards, all values are corrected for 100% recovery.
These recoveries exclude possible, although practically negligible losses occurring during gas chromatography. The recovery of radioactivity was 94.9 ± 5.9% (n = 5), when [7a- 
Specificity
The specificity of the method has been investigated by combined gas chromatography-mass spectrometry and by mass fragmentography. The mass spectra, taken from the derivatives of the urinary steroids, were identical with those of the derivatives of the reference standards. The values, measured by mass fragmentography, agreed well with those obtained by gas liquid chromatography. For further details, see (16, 17 
Sensitivity
The sensitivity of the methodlrexgressed as 3 X SD, obtained by using the SD values determined at concentre tion levels below 1 mg/24 h. The smallest amounts differing significantly from zero are given for the individual steroids in Practicability One technician can perform 20 analyses in one working week (5 days). Since the method involves various chromatography, some skill and experience are required. The method has been in use for three years in our laboratory.
Drug interference
The method described here is less susceptible to drug interference as compared with methods which are based on the determination of 17-oxosteroids by the Zimmermann reaction (cf. 2-4). However, it should be stressed that a number of compounds, particularly synthetic steroids, may directly or indirectly interfere with the determination and thereby falsify the result.
Discussion
Since no manageable methods are available for the direct measurement of the glucuronides of 17-oxosteroids, these compounds must be hydrolysed, a process which implies certain problems. Thus, the formation of artefacts can only be avoided if enzymes are used for hydrolysis instead of hot mineral acids. To ensure complete enzymatic hydrolysis of steroid conjugates, it is essential to remove all materials, present in the urine sample, which may inhibit the enzymatic reactions. An efficient way for the removal of interfering substances (e. g. glucuronolactone) is the adsorption chromatography of the urine on Ainberlite XAD-2 according to Bradlow (13); simultaneously, this step leads to a reduction of the volume of the urine sample which facilitates further handling. Even under the mild conditions of enzymatic hydrolysis, some artefacts may arise, whose formation can be successfully prevented by the addition of antibiotics and traces of chloroform to the urine sample (10) . The suggestion of using chromatography on XAD-2 to purify the urine before hydrolysis of the steroid conjugates was made'in 1974 (16) ; since then, the advantages of this procedure have been recognised (18) . In contrast to enzyme preparations of different origin, solvolysis leads to a complete cleavage of steroid sulphates as was found with dehydroepiandrosterone sulphate as test compound. Using the well-known method ofBurstein &Lieberman (14) , no formation of artefacts during solvolysis was noted; this agrees with reports by other authors (11, 19, 20, 21) . The use of internal radioactive standards allows the calculation of 100% recovery. The rates of recovery are almost identical for both [7a- The application of a special two-dimensional thin-layer chromatography leads to a concentration of the 17-oxosteroid and pregnanediol fraction which means that only tiny spots have to be eluted from the thin-layer plates. This reduces the amount of nonspecific material which may otherwise interfere with the gas Chromatographie determination. The technique of two-dimensional thinlayer chromatography allows the application of the sample as a line, resulting in an improved resolution.
The stationary phase for gas-liquid chromatography (OV 210/OV 225, 1:1.8), as described in the present paper, permits the complete resolution of the individual steroids within 15 min at a constant temperature. This is a major advantage; compared with the temperature programming of the column oven, isothermal gas-liquid chromatography reduces the time for analysis, increases the reproducibility and facilitates mechanization. Moreover, the phase OV 210/OV 225 is superior to the phase XE-60 because of its higher thermal stability. Typical gas chromatograms are shown in figures 1 a-1 c.
The special feature of the present method is the simultaneous and highly specific determination of seven 17-oxosteroids and pregnanediol. The specificity is based (1) on the chromatography of the urine on Amberlite XAD-2, (2) on the two-dimensional thin-layer chromatography and (3) on the gas chromatography of the MSTFA derivatives of the steroids. For each individual steroid, the specificity as well as the accuracy of its determination were proven by mass fragmentography (16, 17) .
The normal urinary excretion of 17-oxosteroids varies with age, rising slowly from birth to puberty and then rapidly to a maximum in the mid-twenties (males: 8-26 mg/24 h, mean 15 mg/24 h; females: 4-17 mg/ 24 h, mean 10 mg/24 h) (22) . Excretion in both sexes declines during senescence. Although the average for males is higher than that of females of comparable age, the scatter is quite large, and there is considerable overlap of values. The daily excretion of 17-oxosteroids in the young adult varies marginally from day to day. Of the total, 70-85% is found in the glucuronide fraction, which contains measurable amounts of all compounds except dehydroepiandrosterone. The remainder of the urinary 17-oxosteroids (15-30%) appear in the sulphate fraction, of which dehydroepiandrosterone is frequently the major component. Representative values for the individual 17-oxosteroids and pregnanediol are shown in table 4. The total amount of 17-oxosteroids excreted in urine per 24 h does not depend on the intake of fluid (23) .
The simultaneous determination of individual 17-oxosteroids and pregnanediol is of great value in the diagnosis of the adreno-genital syndrome and in the differentiation of the various forms of enzyme deficiency, underlying this disease. In patients with a 30-hydroxysteroid-oxidoreductase deficiency, the excretion of dehydroepiandrosterone is elevated, whereas that of the other 17-oxosteroids and of pregnanediol drops to undetectable values. In 11/3-hydroxylase deficiency, the Tab. 4. Urinary excretion of individual 17-oxosteroids and pregnanediol in normal subjects and in a girl (11 years) with an adrenal cortex bias to m a before and after operation. .14 --excretion of the 11-oxygenated 17-oxosteroids is markedly decreased and that of the 11-deoxy-17-oxosteroids as well as of pregnanediol increased. In 21-hydroxylase deficiency, the excretion of 17-qxpsteroids is significantly elevated.
The diagnosis of carcinoma of the adrenal cortex is facilitated by the determination of individual 17-oxosteroids; here, an unusual high excretion of dehydroepiandrosterone is regularly observed.
Furthermore, the differential determination of 17-oxosteroids may be useful in the evaluation of (a) hypothalamic-hypophyseal disorders, such as dystrophia adiposo^genitalis (Fr hlich** syndrome), anorexia nervosa and hypopituitarism, and (b) gonadal disorders, such as Stein-Leventhal syndrome and arfhenoblastoma.
There can be no doubt that the determination of individual 17-oxosteroids will contribute to the elucidation of many endocrinological disorders which are at present poorly understood.
